$NOC

Northrop Grumman Q3 Earnings, Sales Rise; Shares Up Pre-Bell

Northrop Grumman reported Q3 earnings and sales growth, with shares rising in pre-market trading. The company expects 2026 sales between $43.75B and $44.25B, slightly below FactSet estimates of $44.07B.

Original reporting
Published Oct 20, 2026, 10:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 10:55 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NOC
Neutral
medium confidence
Mentioned
$NOC
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$NOCNeutralMed
01

Why it matters

Northrop Grumman's Q3 earnings and sales outlook provide fresh data for traders to adjust positions.

02

Market read

Earnings and guidance release for a large‑cap defense firm, directly affecting its stock price.

03

What to watch

Potential upside from upcoming contract awards not reflected in the guidance.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

The article is a brief earnings summary with no additional commentary or analysis.

Company-level read

Ticker impact

$NOCNeutralMedium confidence
Context

Northrop Grumman reported Q3 earnings and provided a 2026 sales outlook of $43.75B‑$44.25B, slightly below consensus estimates.

Expected impact

likely modest pressure as market prices in the guidance shortfall

Evidence & confidence

The sales range is close to estimates, so the move is expected to be limited.

Market effects

Defense sector may see slight re‑rating as a major contractor's guidance misses consensus.

U.S. defense stocks could experience modest adjustments.

Limited; primarily impacts U.S. defense equities.

Counterpoint

Investors could view the guidance as a buying opportunity if they expect defense spending to rise.

Key entities

  • Northrop Grumman

    U.S. defense contractor reporting Q3 results.

Related articles

$NOCHighAI 8/10

Northrop Grumman (NOC) Q3 2026 Earnings Call Transcript

Northrop Grumman (NOC) reported Q3 2026 earnings with a 1.5x book-to-bill ratio, a record $110B backlog, and 12%+ operating margins. The company raised 2026 guidance and expects growth acceleration in 2027, driven by programs like Sentinel, B-21, and space systems. New products and strategic wins support long-term expansion, with international sales targeted to double by 2031.

$NOCMedAI 8/10

Northrop Grumman Corporation Q3 2026 Earnings Call Summary

Northrop Grumman reported Q3 2026 earnings, highlighting a record $110B backlog and 14% sales growth in Aeronautics. The company raised EPS guidance and expects 5-7% sales growth in 2027, with margin expansion. Capital expenditures are projected at $2.1B for 2027, and international sales are targeted to double by 2031. Management is exploring strategic options for its quantum and microelectronics business.

$NOCHighAI 8/10

Northrop Grumman (NOC) Stock Trades Up, Here Is Why

Northrop Grumman (NOC) shares rose 5.2% after reporting Q3 2026 sales of $11.1B (up 7% YoY) and EPS of $7.89 (beating estimates). The company raised its full-year guidance for operating income and EPS. Its backlog increased to $110B, and operating margin was 11.4%. NOC is down 8.3% YTD but up 34% over 5 years.

$NOCHighAI 8/10

What Northrop Grumman (NOC) Said on Its Q3 Earnings Call

Northrop Grumman (NOC) reported Q3 progress, including Sentinel missile development, satellite deployments, and a $1.4B backlog addition. It raised 2026 segment operating income guidance to $4.94B-$5.04B and EPS by $0.70. For 2027, it forecasts 5%-7% sales growth, margin expansion, and $3.3B-$3.7B free cash flow. The company is exploring strategic options for its microelectronics business.